Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces. METHODS: We conducted surveys in 2007 of all manufacturers (n = 253) and of 59 purposively selected retail and 63 hospital pharmacies in Shandong and Gansu provinces to assess production and supply of products on the 2004 National Essential Medicines List (NEML), as well as factors underlying decision making about production and supply. We also reviewed prescriptions (n = 5456) in health facilities to calculate standard indicators of appropriate medicines use. RESULTS: Overall, manufacturers in Shandong and Gansu produced only 62% and 50%, respectively, of the essential medicines they were licensed to produce. Of a randomly selected 10% of NEML products, retail pharmacies stocked up to 60% of Western products. Median availability in hospital pharmacies ranged from 19% to 69%. Manufacturer and retail pharmacy managers based decisions on medicines production and stocking on economic considerations, while hospital pharmacy managers cited clinical need. Between 64% and 86% of prescriptions contained an essential medicine. However, overprescribing of antibiotics (34%-77% of prescriptions) and injectables (22%-61%) for adult non-infectious outpatient consultations was common. CONCLUSIONS: We found that manufacturers, retail pharmacies, and hospital pharmacies paid limited attention to China's 2004 NEML in their decisions to manufacture, purchase, and stock essential medicines. We also found that prescribing of essential medicines was frequently inappropriate. These results should inform strategies to improve affordable access to essential medicines under the current health care reform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
25 years of the WHO essential medicines lists: progress and challenges
Laing, R., Waning, B., Gray, A., Ford, N., & 't Hoen, E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13375-2 · Cited by 321
Cited by
Essential medicines are more available than other medicines around the globe
Bazargani, Y. T., Ewen, M., de Boer, A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087576 · Cited by 126
Li, Y., Ying, C., Sufang, G., Brant, P., Bin, L., & Hipgrave, D. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.11.097998 · Cited by 93
Wang, X., Xuan, Z., Storella, T. H., & Zhou, X. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113035 · Cited by 40
Metadata
- Authors
- Chen, W., Tang, S., Sun, J., Ross-Degnan, D., & Wagner, A. K.
- Venue
- BMC Health Services Research
- Published
- 2010-07-17
- Volume
- 10
- Issue
- 1
- Pages
- 211-211
- ISSN
- 1472-6963 (ISSN-L)
- OpenAlex
- W2157842743
- Cited by
- 79
- References
- 1
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. https://app.cochat.ai/papers/10.1186/1472-6963-10-211
- The paper
- Chen, W., Tang, S., Sun, J., Ross-Degnan, D., & Wagner, A. K. (2010). Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Services Research. https://doi.org/10.1186/1472-6963-10-211
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.